Skip to main content
Signal8

Milestone Pharmaceuticals Inc. (MIST)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

NASDAQ:MISTHealthcare
Pre-0.26%$0.7608
Close$0.7628+10.15%AH$0.7600+0.11%since
Mkt Cap$94.97M
Float123.66M
O/S124.5M
PM VOL1K sh
$ Vol≈$861
RVOL0.13×
Inst Own40.8%
SI15.9%
EarningsNov 11 · in 2d
Dilution
Milestone Pharmaceuticals Inc. logoNASDAQ:MISTPre$0.7608-0.26%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 20260.72000.76990.70210.7628556,418
Nov 5, 20260.76140.78500.67520.69251,193,079
Nov 4, 20260.77740.79990.75000.7725696,025
Nov 3, 20260.72000.76610.72000.7593566,027
Nov 2, 20260.77080.77990.72020.7211748,836
Oct 30, 20260.79000.79970.72590.7300730,165
Oct 29, 20260.75740.83630.74840.7896796,930
Oct 28, 20260.70320.76990.68790.7574832,654
Oct 27, 20260.65000.69600.64400.6912754,472
Oct 26, 20260.65000.66820.63070.6444802,492
Oct 23, 20260.71000.71000.63380.64821,576,365
Oct 22, 20260.69000.73900.69000.7027621,339
Oct 21, 20260.72000.72790.69500.6953673,279
Oct 20, 20260.70000.74490.70000.7185502,308
Oct 19, 20260.71900.73990.69610.7001669,893
Oct 16, 20260.80000.80000.70400.7073980,764
Oct 15, 20260.78620.79940.75200.79451,036,708
Oct 14, 20260.76130.80350.75010.7879807,115
Oct 13, 20260.79240.81090.75100.76581,199,730
Oct 12, 20260.78000.81410.74000.80551,172,682
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$3.00+293.3%
Low $3High $3
Ratings Distribution
BUY
6
HOLD
1
SELL
0
TOTAL7
Insider Trades
InsiderTypeShares
TOMSICEK MICHAEL JOHN profile photoTOMSICEK MICHAEL JOHNGrant/Award77.0K
Saik Andrew profile photoSaik AndrewGrant/Award77.0K
PAPA JOSEPH C profile photoPAPA JOSEPH CGrant/Award77.0K
Giles Lisa M. profile photoGiles Lisa M.Grant/Award77.0K
Wills Robert James profile photoWills Robert JamesGrant/Award77.0K
Fischer Seth H. Z. profile photoFischer Seth H. Z.Grant/Award77.0K
Shareholders
40.8%
Institutional
(80)
0.9%
Insiderⓘ
(8)
6.4%
5%+ Owners
(1)
51.9%
Unattributed (incl. retail)ⓘ
Institutional40.8%
Insider0.9%
5%+ Beneficial6.4%
Unattributed (incl. retail)51.9%
Sources: 13F, Form 4, 13D/13GO/S: 124.5M · as of 12 Aug 2026 · SEC filings
Insiders & Institutional Holders

Insiders

Top institutional holders

About

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines.

The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate.

It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans.

The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Key Metrics
Market Cap$94.97M
Enterprise Value--
P/E Ratio-1.67
Est. Net Cash/Share--
Institutional Ownership40.81%

based on 124.50M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryCACA
IPO DateMay 9, 2019
Shares Outstanding124.50M
Authorized Shares
Float123.66M
52-Week Range
$0.6307$3.06
$0.7628(5th percentile)
Volume
Average Daily Volume845.86K
556.42K today vs 845.86K avg(-34%)

30d Avg

845.86K

60d Avg

1.11M

90d Avg

1.33M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...